Healthcare Distribution Alliance – Patients Move Us.
Share Print



Results: 48 Articles found.
  • HDA Statement on “Project Airbridge” Initiative
    March 29, 2020

    Healthcare Distribution Alliance (HDA) President and CEO Chester “Chip” Davis, Jr., released the following statement regarding today’s White House Coronavirus Task Force briefing and the “Project Airbridge” initiative.

  • HDA Statement on FDA Drug Importation Proposal
    March 9, 2020

    In response to the Food and Drug Administration’s (FDA) proposed rule on prescription drug importation, Healthcare Distribution Alliance (HDA) President and CEO Chester “Chip” Davis, Jr. released the following statement:

  • HDA Statement on COVID-19 Preparedness
    March 5, 2020

    The Healthcare Distribution Alliance (HDA) released the following statement on distribution industry preparedness for the novel COVID-19 “coronavirus” outbreak.

  • AAOA Celebrates Two Years of Working with Stakeholders to Help Address Prescription Opioid Safety
    February 25, 2020

    This month, Allied Against Opioid Abuse (AAOA) celebrates its second year of working with stakeholders across the healthcare industry to raise awareness among patients, pharmacists, providers and the public about prescription opioid safety.

  • Conley and Cowman to Lead HDA Research Foundation Board Of Directors
    February 25, 2020

    The HDA Research Foundation announced Michael Conley, Vice President and Head, Trade Operations and Analytics, Novartis Pharmaceuticals Corporation, as Chairman of its Board of Directors. Craig Cowman, Executive Vice President, Global Sourcing, Cardinal Health, is Vice Chairman.

Media Contacts

John Parker
(703) 885-0216

Elyse Petroni
(703) 885-0221

Farah Simonett
(703) 885-0269

© 2020 Healthcare Distribution Alliance. All rights reserved.
HDA: E | C | C2 | NF | O365